Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition

Demmer RT, Zuk AM, Rosenbaum M, Desvarieux M (2013) Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999–2010. Am J Epidemiol 178(7):1106–1113 Ma RC, Lin X, Jia W (2014) Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol 2(12):980–991 Pitts-Tucker T (2012) Asian and Afro-Caribbean Britons have double the risk of type 2 diabetes. Br Med J 345:e6135 Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C (2013) Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159(8):543–551 Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498(7452):99–103 Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60 Zhang X, Shen D, Fang Z et al (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8(8):e71108 de Vos WM, Nieuwdorp M (2013) Genomics. A gut prediction. Nature 498(7452):48–49 Lau E, Carvalho D, Pina-Vaz C, Barbosa JA, Freitas P (2015) Beyond gut microbiota: understanding obesity and type 2 diabetes. Hormones 14(3):358–369 Barsoum RS (2006) Chronic kidney disease in the developing world. N Engl J Med 354(10):997–999 Du P, Fan B, Han H et al (2013) NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 84(2):265–276 Zhang L, Long J, Jiang W et al (2016) Trends in chronic kidney disease in China. N Engl J Med 375(9):905–906 de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305(24):2532–2539 Afkarian M, Sachs MC, Kestenbaum B et al (2013) Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 24(2):302–308 Fineberg D, Jandeleit-Dahm KA, Cooper ME (2013) Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol 9(12):713–723 Li L, Ma L, Fu P (2017) Gut microbiota-derived short-chain fatty acids and kidney diseases. Drug Des Dev Ther 11:3531–3542 Ramezani A, Raj DS (2014) The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25(4):657–670 Cai L, Wu H, Li D, Zhou K, Zou F (2015) Type 2 diabetes biomarkers of human gut microbiota selected via iterative sure independent screening method. PLoS One 10(10):e0140827 Guo Z, Zhang J, Wang Z et al (2016) Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep 6:20602 Vaziri ND, Wong J, Pahl M et al (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83(2):308–315 Levey AS, de Jong PE, Coresh J et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80(1):17–28 Bakris GL, Agarwal R, Chan JC et al (2015) Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial. JAMA 314(9):884–894 Brenner D, Hiergeist A, Adis C et al (2018) The fecal microbiome of ALS patients. Neurobiol Aging 61:132–137 Hiergeist A, Reischl U, Gessner A (2016) Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. Int J Med Microbiol 306(5):334–342 Mcardle BH, Anderson MJ (2011) Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 82(1):290–297 Zapala MA, Schork NJ (2006) Multivariate regression analysis of distance matrices for testing associations between gene expression patterns and related variables. Proc Natl Acad Sci USA 103(51):19430–19435 Chow J, Tang H, Mazmanian SK (2011) Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 23(4):473–480 Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336(6086):1268–1273 Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904 Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528(7581):262–266 De Angelis M, Montemurno E, Piccolo M et al (2014) Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One 9(6):e99006 Jiang S, Xie S, Lv D et al (2017) Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep 7(1):2870 Poesen R, Windey K, Neven E et al (2016) The influence of CKD on colonic microbial metabolism. J Am Soc Nephrol 27(5):1389–1399 Nicholson JK, Holmes E, Kinross J et al (2012) Host–gut microbiota metabolic interactions. Science 336(6086):1262–1267 Chen T, Zhang X, Long Y et al (2012) The association of plasma free amino acids with liver enzymes in Type 2 diabetic patients. J Endocrinol Investig 35(8):772–775 Li M, Wang X, Aa J et al (2013) GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol 304(11):F1317–F1324 Nakamura H, Jinzu H, Nagao K et al (2014) Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients. Nutr Diabetes 4:e133 Scanlan PD, Shanahan F, Clune Y et al (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10(3):789–798 Vitali B, Ndagijimana M, Cruciani F et al (2010) Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 10:4 Sun L, Ma L, Ma Y, Zhang F, Zhao C, Nie Y (2018) Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell 9(5):397–403 Andrade-Oliveira V, Amano MT, Correa-Costa M et al (2015) Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol 26(8):1877–1888 Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39(3):230–237 Furusawa Y, Obata Y, Fukuda S et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450 Finegold SM, Dowd SE, Gontcharova V et al (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4):444–453 Rizzatti G, Lopetuso LR, Gibiino G et al (2017) Proteobacteria: a common factor in human diseases. Biomed Res Int 2017(9):1–7 Wassenaar TM, Zimmermann K (2018) Lipopolysaccharides in food, food supplements, and probiotics: should we be worried? Eur J Microbiol Immunol 8(3):63–69 Carrero JJ, Stenvinkel P (2009) Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 4(Suppl 1):S49–S55 Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB (2013) Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26(4):822–880 Clark DP (1989) The fermentation pathways of Escherichia coli. FEMS Microbiol Rev 63(3):223–234 Liu J (2014) Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol 20(40):14672–14685 Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, Zununi Vahed S (2017) The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother 93:412–419